Aaron E. Alt
Aaron E. Alt's purchase track record
Aaron E. Alt has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 8/25/2026 | KDP | $250K | pending | pending | — |
| 6/21/2022 | SYY | $80K | -0.1% | -1.0% | +1.5% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Cardinal Health Hits Record Highs as Sector Strength Continues. Cardinal Health's stock has reached record highs, outperforming the broader market as the healthcare sector shows strong momentum. In corporate news, Senior Vice President Shane Abeyratne has joined the Customer Experience Advisory Board of Level AI. Meanwhile, market observers are looking ahead to the company's upcoming Q1 2027 earnings report and its position as a defensive option in the current economic environment.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Sysco Ends Strike, Morgan Stanley Raises Price Target. Sysco has reached an agreement with Teamsters locals to end its ongoing strike, resolving a key operational uncertainty. This development coincides with Morgan Stanley raising its price target to $91 while maintaining an Equal-Weight rating. Additionally, billionaire investor Dan Loeb’s Third Point has increased its stake in the company, signaling renewed institutional interest in the food distributor.
Transaction History
| KDP | ▲ Buy | Open Market | 7,862 | $250K | 8/25/2026 | View on chart |
| CAH | ▼ Sell | Open Market | 3,115 | $731K | 8/18/2026 | View on chart |
| CAH | ▼ Sell | Open Market | 12,228 | $2.9M | 8/18/2026 | View on chart |
| CAH | ▼ Sell | Open Market | 13,685 | $3.2M | 8/18/2026 | View on chart |
| CAH | ▼ Sell | Open Market | 12,972 | $3.1M | 8/18/2026 | View on chart |
| CAH | ▼ Sell | Tax Withholding | 30,730 | $7.2M | 8/15/2026 | View on chart |
| CAH | ▲ Buy | Grant | 8,079 | $0 | 8/15/2026 | View on chart |
| CAH | ▲ Buy | Grant | 58,738 | $0 | 8/4/2026 | View on chart |
| CAH | ▼ Sell | Open Market | 2,328 | $525K | 2/18/2026 | View on chart |
| CAH | ▼ Sell | Tax Withholding | 1,914 | $423K | 2/15/2026 | View on chart |
| CAH | ▼ Sell | Open Market | 34,455 | $5.1M | 8/19/2025 | View on chart |
| CAH | ▼ Sell | Open Market | 13,788 | $2.1M | 8/19/2025 | View on chart |
| CAH | ▲ Buy | Grant | 11,363 | $0 | 8/15/2025 | View on chart |
| CAH | ▼ Sell | Tax Withholding | 34,866 | $5.2M | 8/15/2025 | View on chart |
| CAH | ▲ Buy | Grant | 67,448 | $0 | 8/12/2025 | View on chart |
| CAH | ▼ Sell | Tax Withholding | 1,919 | $242K | 2/15/2025 | View on chart |
| CAH | ▼ Sell | Open Market | 2,323 | $253K | 8/19/2024 | View on chart |
| CAH | ▼ Sell | Tax Withholding | 2,481 | $268K | 8/16/2024 | View on chart |
| CAH | ▲ Buy | Grant | 14,271 | $0 | 8/15/2024 | View on chart |
| CAH | ▼ Sell | Tax Withholding | 1,919 | $199K | 2/15/2024 | View on chart |
| CAH | ▲ Buy | Grant | 16,593 | $0 | 8/16/2023 | View on chart |
| CAH | ▲ Buy | Grant | 12,726 | $0 | 2/15/2023 | View on chart |
| SYY | ▼ Sell | Tax Withholding | 672 | $51K | 1/1/2023 | View on chart |
| SYY | ▼ Sell | Tax Withholding | 880 | $72K | 9/1/2022 | View on chart |
| SYY | ▲ Buy | Grant | 6,276 | $0 | 8/18/2022 | View on chart |
| SYY | ▲ Buy | Grant | 27,624 | $0 | 7/29/2022 | View on chart |
| SYY | ▼ Sell | Tax Withholding | 9,471 | $827K | 7/29/2022 | View on chart |
| SYY | ▲ Buy | Open Market | 1,000 | $80K | 6/21/2022 | View on chart |
| SYY | ▼ Sell | Tax Withholding | 658 | $52K | 1/3/2022 | View on chart |
| SYY | ▲ Buy | Grant | 6,702 | $0 | 8/19/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Keurig Dr Pepper Faces Acquisition Uncertainty and Commodity Risk Re‑emergence
Keurig Dr Pepper is navigating uncertainty around a potential acquisition or spin‑off, while commodity price swings are returning to the mix. The 2.64% dividend yield has prompted questions about the company’s payout strategy, and a recent CEO change along with a 2027 beverage push could shift the bullish narrative. Some analysts note that consumer staples stocks, including Keurig Dr Pepper, have lagged this year. The stock is near the top of its 52‑week range and sits close to the $30.73 support level, with an RSI of 69.4 indicating a high‑end reading.
Keurig Dr Pepper Faces Acquisition Uncertainty and Commodity Risk Re‑emergence. Keurig Dr Pepper is navigating uncertainty around a potential acquisition or spin‑off, while commodity price swings are returning to the mix. The 2.64% dividend yield has prompted questions about the company’s payout strategy, and a recent CEO change along with a 2027 beverage push could shift the bullish narrative. Some analysts note that consumer staples stocks, including Keurig Dr Pepper, have lagged this year. The stock is near the top of its 52‑week range and sits close to the $30.73 support level, with an RSI of 69.4 indicating a high‑end reading.